[Applied BioCode Corporation] 2026 Q1 EPS 0.20 NTD
NQ Score
0/100
N1 Content Completeness
7
AI Summary (NQ-processed)
Applied BioCode reported Q1 2026 EPS of 0.20 NTD and revenue of 217 million NTD.